Skip to main content
All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) · Represent organizations that promote research and support growth of biotechnology industry

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • CHARLES PATRICK MICHAELS New on this filing
    Previously held: Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 5
Medicare/Medicaid

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Taxation/Internal Revenue Code

Legislative and regulatory issues affecting innovation, including vaccines.

Trade (domestic/foreign)

Issues related to tarriffs.

Budget/Appropriations

Items related to USDA, FDA, genetic engineering, and regulations associated with biotechnology in the Agriculture/Rural Development/Food and Drug Administration proposed Appropriation measures for FY 2026 (House/Senate).

Health Issues

Public health issues impacting patient access to treatments. Updates and reforms to regulation of treatment development and research.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem